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Abstract
Background:  Paroxysmal atrial fibrillation (PAF) is defined as recurrent AF terminating 
spontaneously within 7 days. This definition allows the consideration of any AF occurrence 
lasting < 7 days as paroxysmal, irrespective of the frequency and duration of episodes. The aim 
of this study was to investigate symptomatic AF burden (AFB) defined as total duration of 
symptomatic AF episodes within 3 months prior to abalation, for prediction of outcome after 
pulmonary vein isolation (PVI).                                                                                     
Methods:  A total of 320 consecutive patients with symptomatic AF (PAF=244, men=214, 
age=58 y) were enrolled. AFB in patients with PAF was defined as time spent in AF within 3 
months prior to PVI. After the AFB cut-off point was optimized at 500 h, patients with PAF 
were categorized into 2 groups: Group 1 - patients with AFB<500 h (n=192), Group 2 - patients 
with AFB≥500 h (n=52). Patients with persistent AF (PersAF, n = 76) comprised control group 
(Group 3). PVI was performed either with irrigated tip catheter (n=215) or using cryoballoon 
(n=105). The endpoint of study was first documented recurrence of AF >30 sec.                          
Results: Symptomatic AFB was found to be appropriate for prediction of outcome after PVI. 
The freedom from AF within 2 years was observed in 69%, 31%, and 43% patients in Group 1, 
2 and 3, respectively (Group 1 vs. Group 2, p <.001; Group 1 vs. Group 3, p< .001; Group 2 vs. 
Group 3, p = 0.46).                                                                                          
Conclusions:  Low AFB < 500 h /3 months was associated with better outcome after PVI. 
Patients with PAF and high AFB should be treated as patients with PersAF.                            
Key words:  atrial fibrillation; atrial fibrillation burden; pulmonary vein isolation; catheter 
ablation;   prediction;   outcome                                                                          
Introduction
Pulmonary vein isolation (PVI) has been shown to be effective for treatment of paroxysmal 
atrial fibrillation (PAF) [1-3]. However, in up to 40 % of patients with PAF, a re-do procedure 
may be required [4]. Generally, the primary success rate of PVI is lower in patients with 
persistent AF compared with PAF [5]. Lower success rates have also been seen in patients with 
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significant structural heart disease [6]. Other predictors of poor outcome include significant left 
atrial (LA) enlargement (>55 mm) and advanced age (>65 years) [7].                               
A   recently   published   Expert   Consensus   Statement   has   recognized   the   significance   of 
symptomatic status at enrollment for outcome after PVI [8]. The assessment of symptoms is 
particularly important in patients with PAF. According to the definition of HRS/EHRA/ECAS, 
PAF is defined as recurrent AF (>2 episodes) that terminates spontaneously within 7 days [5, 8]. 
This definition allows considering any AF lasting < 7 days as paroxysmal, irrespective of the 
frequency and duration of episodes within the observation period. The quantitative evaluation of 
symptomatic AF is possible by estimation of AF burden (AFB). The aim of this study was to 
assess the usefulness of symptomatic AFB, defined as total duration of AF episodes within 3 
months prior to first ablation for AF, on maintenance of sinus rhythm during 2 years of follow-
up (primary endpoint). The secondary endpoint was to identify the cut-off point for AFB in 
patients with paroxysmal AF allowing patients at high and low risk of AF recurrence within 2 
years follow up to be discriminated between. The impact of short and long left atrial diameters 
evaluated   in   four-chamber   echocardiography   projection   on   outcome   after   PVI   was   also 
investigated   in   this   study.                                                                                    
  
Methods
Baseline data
A total of 320 consecutive patients with symptomatic AF refractory to beta-blockers and to ≥1 
antiarrhythmic drug including class I agents, sotalol, and amiodarone, were enrolled into the 
study. The baseline characteristics of patients are shown in Table 1. 
Assessment of AF burden                                                                                     
Three months prior to the procedure, patients with PAF were asked to keep a diary of their 
symptoms. AFB was calculated as total duration of AF episodes recorded in the diary as 
described in our previous study [9].  We decided to use this approach again because of the 
simplicity as well as reliability of evaluation and because other methods such as continuous 7-
day Holter ECG monitoring provide limited information due to the short duration of the 
recording, whereas transtelephonic ECG monitoring is not widely applicable in routine clinical 
practice. Furthermore, in previously published studies the incidence of asymptomatic AF has 
been shown to increase up to 37% after ablation, but only 5% were fully asymptomatic before 
the procedure [10, 11]. The last reason for using this approach was follows: we recognize that 
symptoms reported by patient cannot fully reflect real AF episodes. The important question is 
whether the residues between reported symptoms and actual number AF episodes which have 
occured are randomly distributed or have systematical pattern. In the first case the AF burden as 
calculated in our study is random number and subsequently can not be revealed as significant 
predictor in ROC analysis. In other case the residues are systemically distributed and the 
parameter can be used for diagnostics. In details this issue is described below in paragraph 
'statistical analysis'.
Ablation   procedures                                                                              
In 108 patients, 422 PVs were isolated using a 3.5 mm irrigated tip-catheter (5-mm Tip, Celsius 
Thermo-CoolTM, Biosense Webster). The cut-off temperature of generator was 42º C and energy 
delivery was limited to a maximum of 35 W. Successful ablation was defined as a complete 
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disappearance of the fragmented signals during mapping with a decapolar Lasso catheter (Lasso 
TM, Biosense Webster) at the PV antrum. If there were residual signals recorded after ablation, 
the site was paced to determine whether the far field signals were present.
Table 1: Baseline characteristics 
Continuous data are given as median (IQR). * AF burden was defined 
as total duration of symptomatic AF episodes in patients with 
paroxysmal AF within 3 months prior to ablation.  LASD-Left atrial 
short diameter; LALD-Left atrial long diameter 
In other 107 patients treated with radiofrequency, mapping was performed using high density 
mapper (MESH. Bard inc. USA). We started an ipsilateral isolation of both sides. The complete 
loss of PV and antral atrial signals under the mapping electrodes was defined as complete antral 
PVI.  
In the remaining 105 patients, 420 PVs were isolated using a 23 mm or 28 mm cryo balloon. If 
necessary, the residual gap was closed using the large tip catheter FreezorMaxTM. Mapping was 
performed by either a suitable Lasso catheter or a 3-D mapping system (NavXTM). The balloons 
were advanced into the antrum. The balloon was inflated and the degree of occlusion was tested 
by contrast injection under fluoroscopic control. Ablations at a single site were repeated with 
guide wire positions in different branches of the PV to obtain better tissue contact in different 
parts of the antrum. If complete isolation with one balloon size could not be achieved, another 
balloon size and/or a larger tip were used to complete the PVI. The baseline data of patients 
according to ablation technique are shown in the Table 1.                                    
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In 244 patients considered according to the definition of HRS/EHRA/ECAS as having PAF only 
PVI was performed.  In remaining 76 patients with persistent AF, irrespective of the energy used 
for PVI, additional linear lesions such as a roof line and the mitral isthmus line were also 
performed   using   a  radiofrequency   catheter.                                                              
Assessment of  the  left  atrial size                                                                         
Left   atrial   short   and   long   diameters   (LASD   (parasternal   measurement);   LALD-apical 
measurement) were assessed in the apical four-chamber projection [12] (Figure 1). 
Figure 1: Measurement of left atrial size performed using apical four-chamber projection. 
LASD- left atrial short diameter; LALD-left atrial long diameter
Follow   up                                                                                                
All patients were seen in our outpatient clinic 3 months after catheter ablation and every 3 
months thereafter for 2 years and additionally in the case of symptomatic recurrence of AF. A 7-
day Holter ECG was performed at each follow-up visit. After discharge, patients treated with 
antiarrhythmic drugs prior to ablation, received the same antiarrhythmic drug therapy during the 
first 3 months. If sinus rhythm was maintained, antiarrhythmic therapy was terminated three 
months after PVI. Beta-blockers were continued in patients with hypertension or coronary artery 
disease. The endpoint of the study was the first documented AF recurrence >30 s. The first three 
months after ablation were considered as a blanking period.                                             
Statistical   analysis                                                                                  
This study was designed as a validation cohort study. Our aim was to test whether the AFB 
calculated based on patients' symptoms and left atrial diameters may be used for prediction of 
outcome and if yes to define and validate cut-off values for both parameters that would allow 
discriminating between patients with high and low risk of AF recurrence after ablation. To solve 
this issue ROC curve analysis should be performed [13].
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In the case of absence of the gold standard or if independent data set is not available, the 
parameters of interests should be analyzed by randomization of study patients in two groups - 
one to derive the model and the other to validate it [13]. We randomly allocated 244 patients 
with PAF into two subsets of 122 each - the training set and the validating set. The data for 
patients randomized to training and validating sets are shown in the Table 2. The cut-off values 
for AFB and both diameters of the left atrium were estimated using maximum likelihood ratio 
(LR) derived from the ROC-curve analysis based on a training set. After the cut-off values were 
defined in the training set, they were tested in the validating set. Area under ROC curve, positive 
and negative predictive accuracy (PPA, NPA) of defined cut-offs were calculated.   After 
predictive accuracy of cut-off values was confirmed in the validating set, the patients were 
clustered together. Furthermore, the patients with PAF were categorized into 2 groups according 
to the defined cut-off point of AFB: Group 1 - patients with AFB< cut-off and Group 2 - patients 
with AFB≥ cut-off. The remaining 76 patients with persistent AF were considered as a control 
group (Group 3). The outcome was analyzed using Kaplan-Meier analysis and a multivariate 
Cox   regression   model   with   adjustment   for   all   clinical   variables   included   in   baseline 
characteristics and ablation tools. 
Table 2: Characteristics of the training and validating set 
CAD- Coronary artery disease 
Results
Training   set                                                                        
Out of 122 patients with PAF randomized to training set 45 (36.9 %) reached endpoint. The test 
did not reveal an effect of the applied energy source on the outcome (Table 3). The area under 
the ROC-curve by AFB, left atrial long and short diameters  was .62, .60 and .53, respectively 
(Table 4). Subsequently, left atrial short diameter could not be used for prediction of outcome. 
Maximum likelihood ratio of AFB and left atrial long diameters was found at 500 hours 
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(LR=2.33) and at 60 mm (LR=2.05), respectively. As shown in table 4, positive and negative 
predictive accuracy of AFB by setting the cut-off point at 500 h was 58% and 69%, respectively. 
The predictive accuracy of left atrial long diameter with cut off point of 60 mm. was also 
moderate, PPA-54% and NPA-65%. However, both parameters allowed patients with high and 
low risk of AF recurrences after PVI to be discriminated between.                                      
Table 3: Effect of ablation energy on outcome in patients with paroxysmal atrial fibrillation
Table 4: ROC curve analysis in training and validation set  
Validating   set                                                                                    
As in the training set the effect of the ablation energy could not be revealed (Table 3). The area 
under the ROC curve was .72 and .61 for AFB and LALD, respectively (Table 4). Similar to the 
training set maximum LR=6.05 and 2.24 were found at 500 hours and 60 mm, for AFB and 
LALD, respectively. The PPA was 81% and 61%, and the NPA was 70% and 64%, respectively 
(Table 4). Although the predictive accuracy of dichotomized AFB appeared to be stronger in the 
validating test, the performed z-test (z=1.50, p=.19) did not reveal statistical differences between 
areas under ROC curves. The difference between areas under ROC curves composed for LALD 
could also not be revealed (z=.47, p=.69). Therefore, we can use both of the tested cut-off values 
for the prediction of outcome in the whole group.                                                                     
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Impact of AFB and LALD on outcome after PVI                                          
Out of 320 enrolled patients, 182 (57 %) were free of documented AF recurrence during 2-year 
follow-up. Kaplan-Meier survival analysis has shown that dichotomized AF burden was strongly 
associated with outcome (Figure 2). The log-rank test demonstrated significant differences in 
the likelihood of AF recurrence between Group 1 (n=192), and Group 2(n=52) (χ2=26.11, 
p<.001), and Group 3 (n=76) (χ2=20.17, p<.001). Of note, no significant difference between 
Group 2 and Group 3 was found (χ2=2.43, p=.46).                                                                 
Figure 2: Outcome after catheter ablation in different AF groups
Group 1-paroxysmal AF with AF burden < 500 hours/3 months;
Group 2-paroxysmal AF with AF burden ≥ 500 hours/3 months; 
Group 3-persistent AF
In univariate analysis, AFB ≥ 500 hours, LALD ≥ 60 mm, and the presence of coronary artery 
disease were associated with the recurrence of AF (Table 5). In multivariate analysis, only AFB 
≥ 500 hours/3 months and LALD ≥ 60 mm were independent predictors of AF recurrence. 
Neither ablation tools, nor history of AF, presence of heart disease, and other clinical parameters 
have been shown to be independent predictors of outcome (Table 6). 
The detailed data on outcome according to the energy source used is given in the table 7. No 
impact of energy source was found in patients assigned to Groups 1 and 2. The patients from 
Groups 2 and 3 had overall reduced outcome. However, patients treated with a cryoballoon had 
the highest recurrence rate among patients with persistent AF (Table 7). 
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Table 5: Predictive accuracy in the training and validation set 
PPA- Positive predictive accuracy
NPA-Negative predictive accuracy
LR- Maximum likelihood ratio
Table 6: Association of clinical variables with outcome  
Group ≥2- Patients with PAF and AFB≥ 500 h and patients with persistent AF
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Table 7: Outcome after the procedure according to energy source 
* There is significant difference in outcome within group (p<.01).
The subgroup analysis showed significant differences in outcome between Group 1 and other AF 
groups in patients with LALD< 60 mm. (Figure 3.a). In contrast, no significant differences 
could be found between all AF groups in patients with LALD ≥ 60 mm (Figure 3.b). 
In 27 patients (8.4 %) left atrial tachycardia (LAT) was observed during follow-up. In 19 of them 
(70 %) LAT was transient and in 8 patients (30 %) additional ablation was needed.          
Discussion
The main finding of this study is that symptomatic AF burden can be used for prediction of 
outcome patients with PAF. The quantitative evaluation of symptomatic AFB based on the patient 
diary prior to procedure allowed discrimination between patients in low or high risk groups and 
may be useful for the choice of the appropriate ablation strategy. We found that symptomatic AFB 
before ablation had significantly better outcome, whereas no difference was found between 
patients with PAF and AFB ≥ 500 hours within the last 3 months prior to PVI and patients with 
persistent AF. Poor outcome after PVI in patients with persistent AF and in up to 40% patients 
with PAF was observed in several previous studies [1-6]. On the other hand, up to 25% of patients 
with initially diagnosed PAF progressed to persistent AF [14]. However, patients with frequent 
and/or prolonged episodes of AF who may be referred as "progressing to persistent AF", have not 
been studied as a separate entity. Similar recurrence rates in patients with persistent AF and 
patients with PAF and high AFB ≥ 500 h/ 3 months allow the later group to be considered as 
being in progression to persistent AF.
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Figure 3: Outcome after catheter ablation patients according to LALD
a) LALD < 60 mm; b) LALD≥ 60 mm 
The curves present follow AF groups: 
Group 1 -paroxysmal AF with AF burden < 500 hours/3 months
Group 2 -paroxysmal AF with AF burden ≥ 500 hours/3 months
Group 3 -persistent AF
a) Best outcome shows Group 1, whereas no differences could 
be found between Group 2 and Group 3. 
b) No differences in outcome could be found 
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Important is the fact that patients with low AFB have better outcome irrespective of the ablation 
strategy. For example, these patients may be considered for PVI with the cryoballoon. This 
ablation technique has been shown to be effective for the majority of patients with PAF and free 
from such severe complications as esophageal fistula and PV stenosis as well [15]. Consequently, 
patients with increased AFB should be treated as patients with persistent AF with PVI and 
extended left atrial ablation with radiofrequency energy [16, 17].                                 
The association between the left atrial size and high recurrence rates after ablation was described 
in several previous studies [6, 7, 8, 18]. Although left atrial enlargement may frequently occur 
asymmetrically [12, 19], only short diameter of left atrium has been usually evaluated [6-8]. The 
left atrial volume seems to be a more accurate parameter of left atrial size than left atrial diameter 
[12, 19-21]. However, there is no consensus regarding the standard method for assessment of the 
left atrial volume based on 2-D measurement [19]; the 3-D echo investigation has recently become 
available. Using a four-chamber view, we observed many cases of asymmetric enlargement of the 
left atrium, so that the short diameter was below the upper limit of normal and the long diameter 
was considerably increased (Figure 1). The cut-off point for long diameter which allowed high 
and low risk patients to be discriminated between was 60 mm. Even patients with low AFB prior 
to the procedure but increased long diameter of left atrium were more likely to have AF 
recurrence after single PVI (Figure 3.b).                                                                                     
Conclusion
Our results suggest that patients with PAF and very high AFB must be considered as being in 
progression to persistent AF and accordingly treated. The patients with low AFB and non-dilated 
left atrium have a high probability to be in sinus rhythm after single PVI.                              
Study   limitation                                                                                            
The following limitations of the study should be acknowledged. We could not identify all episodes 
of AF, particularly asymptomatic, because no monitoring was performed before ablation. We 
instead relied on patient self-reports. Furthermore, we only assessed symptomatic burden during a 
limited period of 3 months before ablation. If an implantable loop-recorder was used, it would be 
possible to include potential asymptomatic AF burden into analysis. The last limitation we have to 
mention is   follow up time of 2 years.                                                                                                   
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